CD79A B-Cell Tumor Test | Lahalak Platform
A fundamental diagnostic kit for identifying B-cell-derived tumors, representing the crucial first step in classifying lymphomas and selecting the appropriate treatment protocol.
Scientific name: Immunohistochemistry (IHC): CD79A
This diagnostic package, based on immunohistochemistry, includes the examination of a range of markers to confirm the B-cell origin of lymphoblastic neoplasms. The package primarily includes the examination of CD79a, an early and persistent cytoplasmic component of the B-cell receptor (BCR) complex, making it a highly sensitive and specific marker...
Service type
Laboratory test (Tumor Markers)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Examination of the sensitive cytoplasmic marker CD79a to confirm the origin of the B cell.
- PAX5 specific nuclear factor testing for nuclear confirmation of the B strain.
- Examination of the common membrane marker CD20 to assess B cell maturation.
- Consult a pathologist specializing in lymphomas for an interpretation of the overall results.
Medical Service Information
Conditions & Notices
- It requires the submission of a complete tissue block (paraffin block) of the biopsy specimen (lymph node, bone marrow, or other organ).
- It is necessary to attach the initial pathology report along with a description of the clinical suspicion.
- The patient does not need to fast, as the sample is tissue-based.
- The completion time ranges from 5 to 10 working days.
Medical services you might also like
